Articles > Devices & Technology

T1D Exchange and DreaMed Diabetes Formalize Partnership to Optimize Insulin Treatment Plans in Clinics

Type 1 diabetes decision support technology analyzes patient data from variety of devices to determine insulin delivery recommendations for maintaining balanced glucose levels.

Patch CGM Approved for Use in Europe

Nemaura plans to initially market the SugarBEAT patch CGM, which has predictive glucose alarms, to people with type 2 diabetes.

Medtronic 670G Pump Users Experienced Optimal Blood Sugar Range 71 Percent of the Time

The medtech company unveiled CareLink data showing that the automated basal delivery feature of the pump system helped people with type 1 diabetes experience improved Time in Range.

Pivotal Home Trial of iLet Bionic Pancreas System Announced

The trial is being conducted by Beta Bionics and Zealand Pharma, and marks the first full-scale test of the dual-hormone therapy in a real-world setting.

Senseonics announced a distribution partnership with a verified Service-Disabled Veteran-Owned Small Business to offer the implantable CGM through the Veterans Health Administration.

DIY Automated Insulin Dosing Stakeholders Issue Statement to FDA Warning Against Such Systems

The statement has reportedly been endorsed and co-written by key members of the Loop, OpenAPS, and AndroidAPS movements.

The agency says it has received word of an accidental insulin overdose that occurred with an automated insulin dosing system.

A Blood Glucose Monitor Designed With Consumers, Not Patients, In Mind

How Lonny Stormo’s frustration with meter design led to the creation of POPS! Diabetes Care, and a meter that is elegant enough to double as an iPhone case.

RileyLink founder Pete Schwamb has released the code for others in the #WeAreNotWaiting movement to test run.

The title of this article is in error, and we provide a link to the corrected title.